Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains

References

1. Beutin L., Geier D., Zimmermann S., Karch H. 1995; Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 33:631–635
   [Google Scholar]
2. Brunder W., Schmidt H., Frosch M., Karch H. 1999; The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145:1005–1014 [CrossRef]
   [Google Scholar]
3. CDC 1982; Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis – United States. Morb Mortal Wkly Rep 31:580–585
   [Google Scholar]
4. Fuchs S., Mühldorfer I., Donohue-Rolfe A., Kerényi M., Emödy L., Rossen A., Alexiev R., Nenkov P., Hacker J. 1999; Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog 27:13–23 [CrossRef]
   [Google Scholar]
5. de Graaf G. J., Jager L. P., Baars A. J., Spierenburg Th. J. 1988; Some pharmacokinetic observations of carbadox medication in pigs. Vet Q 10:34–41 [CrossRef]
   [Google Scholar]
6. Greife H. A., Berschauer F. 1988; Leistungsförderer in der Tierproduktion: Stand und Perspektiven. Übers Tierernährg 16:27–78
   [Google Scholar]
7. Grif K., Dierich M. P., Karch H., Allerberger F. 1998; Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 17:761–766 [CrossRef]
   [Google Scholar]
8. Griffin P. M., Tauxe R. V. 1991; The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13:60–98
   [Google Scholar]
9. Gunzer F., Böhm H., Rüssmann H., Bitzan M., Aleksic S., Karch H. 1992; Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol 30:1807–1810
   [Google Scholar]
10. Jacewicz M. S., Acheson D. W., Binion D. G., West G. A., Lincicome L. L., Fiocchi C., Keusch G. T. 1999; Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun 67:1439–1444
    [Google Scholar]
11. Matsushiro A., Sato K., Miyamoto H., Yamamura T., Honda T. 1999; Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 181:2257–2260
    [Google Scholar]
12. Moore P. R., Evenson A., Luckey T. D., McCoy E., Elvehjem C. A., Hart E. B. 1946; Use of sulfasuxidine, streptothricin and streptomycin in nutritional studies with the chick. J Biol Chem 16:437
    [Google Scholar]
13. Mühldorfer I., Hacker J., Keusch G. T., Acheson D. W., Tschäpe H., Kane A. V., Ritter A., Ölschläger T., Donohue-Rolfe A. 1996; Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64:495–502
    [Google Scholar]
14. National Committee for Clinical Laboratory Standards 1993; Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3 Villanova, PA: National Commitee for Clinical Laboratory Standards;
    [Google Scholar]
15. Neely M. N., Friedman D. I. 1998; Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28:1255–1267 [CrossRef]
    [Google Scholar]
16. Ostroff S. M., Griffin P. M., Tauxe R. V., Shipman L. D., Greene K. D., Wells J. G., Lewis J. H., Blake P. A., Kobayashi J. M. 1990; A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol 132:239–247
    [Google Scholar]
17. Pierard D., Muyldermans G., Moriau L., Stevens D., Lauwers S. 1998; Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 36:3317–3322
    [Google Scholar]
18. Richter H., Klie H., Timm M., Gallien P., Steinrück H., Perlberg K. W., Protz D. 1997; Verotoxin-producing E. coli (VTEC) in feces from cattle slaughtered in Germany. Berl Münch Tierärztl Wochenschr 110:121–127
    [Google Scholar]
19. Riedel-Caspary G. 1986; Leistungsförderer in der Schweinemast. DLG-Mitteilung 11:608–619
    [Google Scholar]
20. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
21. Schmidt H., Geitz C., Tarr P. I., Frosch M., Karch H. 1999a; Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis 179:115–123 [CrossRef]
    [Google Scholar]
22. Schmidt H., Scheef J., Huppertz H. I., Frosch M., Karch H. 1999b; Escherichia coli O157:H7 and O157:H^- strains that do not produce Shiga toxin: phenotypic and genotypic characterization of isolates asscoiated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 37:3491–3496
    [Google Scholar]
23. Smith H. W., Green P., Parsell Z. 1983; Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol 129:3121–3137
    [Google Scholar]
24. Spierenburg Th. J., van Lenthe H., de Graaf G., Jager L. P. 1988; Liquid chromatographic determination of olaquindox in medicated feeds and in contents of porcine gastrointestinal tract. J Assoc Off Anal Chem 71:1106–1109
    [Google Scholar]
25. Strockbine N. A., Marques L. R., Newland J. W., Smith H. W., Holmes R. K., O’Brien A. D. 1986; Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53:135–140
    [Google Scholar]
26. Strockbine N. A., Wells J. G., Bopp C. A., Barrett T. J. 1998; Overview of detection and subtyping methods. In Escherichia coli O157:H7 and Other Shiga Toxin-producing E. coli Strains pp. 331–356Edited by Kaper J. B., O’Brien A. D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
27. Trevena W. B., Hooper R. S., Wray C., Willshaw G. A., Cheasty T., Domingue G. 1996; Vero cytotoxin-producing Escherichia coli O157 associated with companion animals. Vet Rec 138:400
    [Google Scholar]
28. Watanabe H., Wada A., Inagaki Y., Itoh K., Tamura K. 1996; Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996. Lancet 348:831–832 [CrossRef]
    [Google Scholar]
29. Williams J. M., Boyd B., Nutikka A., Lingwood C. A., Barnett F. D., Milford D. V., Taylor C. M. 1999; A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 105:47–57 [CrossRef]
    [Google Scholar]
30. Witte W. 1998; Medical consequences of antibiotic use in agriculture. Science 279:996–997 [CrossRef]
    [Google Scholar]